These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21667017)

  • 1. A combination of MSH2 DNA mismatch repair deficiency and expression of the SV40 large T antigen results in cisplatin resistance of mouse embryonic fibroblasts.
    Yasin SL; Rainbow AJ
    Int J Oncol; 2011 Sep; 39(3):719-26. PubMed ID: 21667017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
    Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
    Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for mismatch repair in control of DNA ploidy following DNA damage.
    Strathdee G; Sansom OJ; Sim A; Clarke AR; Brown R
    Oncogene; 2001 Apr; 20(15):1923-7. PubMed ID: 11313940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
    Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
    Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.
    Fink D; Zheng H; Nebel S; Norris PS; Aebi S; Lin TP; Nehmé A; Christen RD; Haas M; MacLeod CL; Howell SB
    Cancer Res; 1997 May; 57(10):1841-5. PubMed ID: 9157971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
    Dregoesc D; Rybak AP; Rainbow AJ
    DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells.
    Cooley N; Elder RH; Povey AC
    Toxicology; 2010 Jan; 268(1-2):111-7. PubMed ID: 20025921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
    Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
    Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis.
    Chen Z; Xu XS; Yang J; Wang G
    Carcinogenesis; 2003 Jun; 24(6):1111-21. PubMed ID: 12807748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts.
    Bhana S; Lloyd DR
    Mutagenesis; 2008 Jan; 23(1):43-50. PubMed ID: 18003626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of an adenovirus encoded reporter gene and its reactivation following UVC and oxidative damage in cultured fish cells.
    Rainbow AJ; Zacal NJ
    Int J Radiat Biol; 2008 Jun; 84(6):455-66. PubMed ID: 18470745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL; Karjalainen HE; Tevethia SS
    J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.
    Liu B; Cvijic ME; Jetzt A; Chin KV
    Cell Growth Differ; 1996 Aug; 7(8):1105-12. PubMed ID: 8853907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers.
    Sonneveld E; Vrieling H; Mullenders LH; van Hoffen A
    Oncogene; 2001 Jan; 20(4):538-41. PubMed ID: 11313985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair.
    Kondo A; Safaei R; Mishima M; Niedner H; Lin X; Howell SB
    Cancer Res; 2001 Oct; 61(20):7603-7. PubMed ID: 11606400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).
    Fedier A; Fink D
    Int J Oncol; 2004 Apr; 24(4):1039-47. PubMed ID: 15010846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint.
    Marquez N; Chappell SC; Sansom OJ; Clarke AR; Court J; Errington RJ; Smith PJ
    Oncogene; 2003 Oct; 22(48):7642-8. PubMed ID: 14576827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.